Caspian Journal of Internal Medicine
Babol University of Medical Sciences
چهارشنبه 6 خرداد 1405
[Archive]
دوره 17، شماره 2 - ( 1-1405 )
جلد 17 شماره 2 صفحات 0-11 |
برگشت به فهرست نسخه ها
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Akhondi V, Shakerian F, sarreshtehdari A, Ghobadi E, Dastmardi M. Comparing the Accuracy of Angioboost Software versus Routine Angiography for assessing the degree of Coronary Artery Lesion Occlusion. Caspian J Intern Med 2026; 17 (2) :11-0
URL: http://caspjim.com/article-1-4767-fa.html
URL: http://caspjim.com/article-1-4767-fa.html
Comparing the Accuracy of Angioboost Software versus Routine Angiography for assessing the degree of Coronary Artery Lesion Occlusion. . 1405; 17 (2) :11-0
چکیده: (74 مشاهده)
Background: Accurate image extraction is essential for simplifying the diagnosis and treatment of coronary artery disease(CAD) and reducing the need for multiple imaging procedures. This study aimed to compare the diagnostic accuracy of AngioBoost knowledge-based software with the standard method of routine angiography in assessing coronary artery lesions.
Methods: This cross-sectional study was conducted on 174 patients undergoing coronary angiography. Patients were included if they exhibited signs and symptoms of ischemic heart disease with an indication for coronary angiography. All participants underwent angiography using the Seldinger method, and the angiographic films were reviewed and interpreted by two independent cardiologists. Subsequently, AngioBoost software was applied to analyze the angiographic images, and its findings were interpreted by two additional cardiologists to assess the software’s diagnostic accuracy.
Results: The contingency coefficient for the first physician's observations using routine angiography and AngioBoost was 74.7%, while the second physician's observations demonstrated a higher agreement at 90.1%. AngioBoost successfully identified 96.3% patent vessels, 79.9% mild lesions, 58.0% moderate lesions, 91.2% significant lesions, and 96.8% completely occluded vessels. The Kappa contingency coefficient varied across different coronary arteries, with 46.8% agreement in Left Main vessels (LMO+LMD), 71.7% in LAD vessels (LADO+LADP+LADM+LADD), 71.0% in LCX vessels (LCXO+LCXP+LCXM+LCXD), and 77.8% in RCA vessels (RCAO+RCAP+RCAM+RCAD).
Conclusion: The findings of this study demonstrate that AngioBoost exhibits an acceptable diagnostic accuracy in assessing the degree of coronary artery occlusion, with an overall contingency coefficient of 88.2%, indicating strong agreement with routine angiography. These results suggest that AngioBoost could serve as a valuable complementary tool for coronary artery disease diagnosis.
Methods: This cross-sectional study was conducted on 174 patients undergoing coronary angiography. Patients were included if they exhibited signs and symptoms of ischemic heart disease with an indication for coronary angiography. All participants underwent angiography using the Seldinger method, and the angiographic films were reviewed and interpreted by two independent cardiologists. Subsequently, AngioBoost software was applied to analyze the angiographic images, and its findings were interpreted by two additional cardiologists to assess the software’s diagnostic accuracy.
Results: The contingency coefficient for the first physician's observations using routine angiography and AngioBoost was 74.7%, while the second physician's observations demonstrated a higher agreement at 90.1%. AngioBoost successfully identified 96.3% patent vessels, 79.9% mild lesions, 58.0% moderate lesions, 91.2% significant lesions, and 96.8% completely occluded vessels. The Kappa contingency coefficient varied across different coronary arteries, with 46.8% agreement in Left Main vessels (LMO+LMD), 71.7% in LAD vessels (LADO+LADP+LADM+LADD), 71.0% in LCX vessels (LCXO+LCXP+LCXM+LCXD), and 77.8% in RCA vessels (RCAO+RCAP+RCAM+RCAD).
Conclusion: The findings of this study demonstrate that AngioBoost exhibits an acceptable diagnostic accuracy in assessing the degree of coronary artery occlusion, with an overall contingency coefficient of 88.2%, indicating strong agreement with routine angiography. These results suggest that AngioBoost could serve as a valuable complementary tool for coronary artery disease diagnosis.
نوع مطالعه: Original Article |
موضوع مقاله:
Cardiology
دریافت: 1404/2/24 | پذیرش: 1404/11/8 | انتشار: 1405/1/4
دریافت: 1404/2/24 | پذیرش: 1404/11/8 | انتشار: 1405/1/4
| بازنشر اطلاعات | |
 |
این مقاله تحت شرایط Creative Commons Attribution-NonCommercial 4.0 International License قابل بازنشر است. |
